A Phase 1 trial testing RAG-17, a potential ALS therapy for people carrying SOD1 mutations, has dosed its first participant.
On December 29, 2024, in Sichuan, China, @Tǐyàntèzhǒngbīngxùnliànyíng shared a video of their son falling while attempting a hanging ring at an amusement park. The author took his son to the park, ...
On January 1, 2025, in Sichuan, China, @Lǐxiǎohù shared a video of her and her friends celebrating the new year 2025 with ...
Photo: VCG A rapid container cargo train left South China's Guangzhou bound for Chengdu, capital of Southwest China's Sichuan ...
One day before a key meeting of China's anti-graft watchdog, the state broadcaster aired a programme on how grassroots ...
A convoy of 212 off-roaders set off from Sichuan-Xizang Highway Museum in Chengdu, Southwest China's Sichuan province, on Dec ...
22h
Two pandas play in the snow in Daxiangling Giant Panda Wild Training and Releasing Base in the Giant Panda National Park on ...
China's weather agency reports record-breaking temperatures in 2024, highlighting the urgent need for climate action globally ...
Shao’s forecasts follow the launch late last month of the first Type 076 warship, a vessel bearing the hull number 51 and named after the southwestern province of Sichuan. With ...
Many of the Chinese airlines flying to Australia offer cheap connections to Europe and other parts of Asia, but what are ...
HSK-21542 is under clinical development by Sichuan Haisco Pharmaceutical and currently in Phase II for Unspecified Toxic Disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback